Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) Short Interest Update

Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) was the recipient of a large decrease in short interest in March. As of March 13th, there was short interest totaling 98,761 shares, a decrease of 72.5% from the February 26th total of 359,584 shares. Based on an average trading volume of 226,804 shares, the short-interest ratio is presently 0.4 days. Approximately 5.8% of the company’s stock are sold short.

Institutional Trading of Defiance Daily Target 2X Long LLY ETF

A hedge fund recently bought a new stake in Defiance Daily Target 2X Long LLY ETF stock. Jump Financial LLC purchased a new position in Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 9,186 shares of the company’s stock, valued at approximately $234,000. Jump Financial LLC owned approximately 0.54% of Defiance Daily Target 2X Long LLY ETF at the end of the most recent reporting period.

Defiance Daily Target 2X Long LLY ETF Trading Down 4.2%

Shares of NYSEARCA LLYX traded down $0.72 during mid-day trading on Thursday, hitting $16.58. 103,170 shares of the stock traded hands, compared to its average volume of 395,801. Defiance Daily Target 2X Long LLY ETF has a 52 week low of $9.60 and a 52 week high of $28.44. The stock has a fifty day moving average price of $21.67 and a 200-day moving average price of $20.91.

Defiance Daily Target 2X Long LLY ETF Announces Dividend

The company also recently disclosed an annual dividend, which was paid on Wednesday, December 31st. Shareholders of record on Tuesday, December 30th were given a dividend of $0.7042 per share. The ex-dividend date of this dividend was Tuesday, December 30th. This represents a yield of 273.0%.

Defiance Daily Target 2X Long LLY ETF Company Profile

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.